Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control. [electronic resource]
Producer: 20120606Description: 14 p. digitalISSN:- 1475-2840
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Aged, 80 and over
- Albuminuria -- etiology
- Biomarkers -- blood
- Bisoprolol -- therapeutic use
- Carbazoles -- therapeutic use
- Carvedilol
- Diabetes Mellitus, Type 2 -- blood
- Diabetic Nephropathies -- etiology
- Female
- Glomerular Filtration Rate -- drug effects
- Glycated Hemoglobin -- metabolism
- Heart Failure, Systolic -- complications
- Hospitals, Teaching
- Humans
- Hypoglycemic Agents -- therapeutic use
- Lipids -- blood
- Male
- Middle Aged
- Propanolamines -- therapeutic use
- Prospective Studies
- Time Factors
- Treatment Outcome
- Victoria
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.